Michel Farnier

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Cross Sectional

Low Density Lipoprotein

Atomic Force Microscopy

Aortic Stenosis

Top Venues

European journal of preventive cardiology

Arteriosclerosis, thrombosis, and vascular biology

Cardiovascular research

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie Béliard, Samir Saheb, Stéphanie Litzler-Renault, Alexandre Vimont, René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology (2024)
David Masson, Damien Leleu, Michel Farnier, Fréderic Chagué, Chloé Rampon, Florence Bichat, Caroline Demeule, Maud Maza, Jean-Paul Pais de Barros, Yves Cottin, Marianne Zeller
Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction. Cardiovascular research (2024)
David Masson, Damien Leleu, Michel Farnier, Fréderic Chagué, Chloé Rampon, Florence Bichat, Caroline Demeule, Maud Maza, Jean-Paul Pais de Barros, Yves Cottin, Marianne Zeller
Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction. Cardiovascular research 120 (2) (2024)
Sophie Béliard, Samir Saheb, Stéphanie Litzler-Renault, Alexandre Vimont, René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
David Masson, Damien Leleu, Michel Farnier, Fréderic Chagué, Chloé Rampon, Florence Bichat, Caroline Demeule, Maud Maza, Jean-Paul Pais de Barros, Yves Cottin, Marianne Zeller
Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction. Cardiovascular research 120 (2) (2024)
Sophie Béliard, Samir Saheb, Stéphanie Litzler-Renault, Alexandre Vimont, René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Jean Ferrières, Éric Bruckert, Michel Farnier, Michel Krempf, Jean-Jacques Mourad, Baptiste Roux, Francois Schiele
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study. Journal of comparative effectiveness research (2023)
Isabelle M Kouame, Michel Farnier, Frédéric Chague, Maud Maza, Florence Bichat, Marianne Zeller, Yves Cottin
Effect of lipoprotein (a) levels on coronary lesion complexity in patients with acute myocardial infarction : data from the French RICO Survey. European journal of preventive cardiology (2023)
Michel Farnier, Raul Dias Dos Santos Filho, Juan Cosín Sales, Marat V Ezhov, Jian Liu, Denis Granados, Serena Santoni, Irfan Khan, Alberico Luigi Catapano
Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries. European journal of preventive cardiology 29 (17) (2022)
Michel Farnier, Raul Dias Dos Santos Filho, Juan Cosín Sales, Marat V Ezhov, Jian Liu, Denis Granados, Serena Santoni, Irfan Khan, Alberico Luigi Catapano
Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries. European journal of preventive cardiology 29 (17) (2022)
Michel Farnier, Raul Dias Dos Santos Filho, Juan Cosín Sales, Marat V Ezhov, Jian Liu, Denis Granados, Serena Santoni, Irfan Khan, Alberico Luigi Catapano
Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries. European journal of preventive cardiology 29 (17) (2022)